The proposed merger between health insurers Aetna and Humana would greatly reduce market competition for Medicare Advantage beneficiaries in the markets they serve, according to a new analysis by the Center for American Progress. “The Medicare Advantage market is currently highly concentrated,” the report notes. “CAP’s analysis of the overlap between Aetna and Humana in Medicare Advantage markets adds to other analyses that show that the proposed merger between the two companies would only exacerbate this trend, likely resulting in higher premiums for seniors and higher costs for the Medicare program.”

Related News Articles

Headline
The Department of Health and Human Services’ Office of Inspector General last week announced its intent to investigate Medicare Advantage Organizations’ prior…
Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…
Headline
The Centers for Medicare & Medicaid Services June 28 released a proposed rule on mitigating the impact of significant, anomalous and highly suspect (SAHS)…
Headline
The Department of Health and Human Services June 26 announced beneficiary coinsurance reductions for 64 prescription drugs available through Medicare Part B.…
Perspective
For too long and for too many patients, the process of obtaining prior authorization for a medical procedure or medicine has been a tangled web, as people are…
Headline
The AHA June 14 sent a letter to the Senate Finance Committee, responding to questions included in a white paper the committee wrote on chronic care through…